By Amnon Ron|2022-10-17T08:48:06+00:00October 17th, 2022|All|Comments Off on Prof. Mohamed Kharfan Dabaja – Positive Results from Final Progression-Free Survival Analysis of zanubrutinib Compared to ibrutinib in CLL
By Amnon Ron|2022-07-26T20:47:32+00:00July 26th, 2022|All|Comments Off on Prof. Selim Corbacioglu – The importance of veno-occlusive disease prophylaxis
By Amnon Ron|2022-07-08T10:52:25+00:00July 8th, 2022|All|Comments Off on Prof. Paul Richardson – Melflufen for the treatement of relapsed-refractory myeloma
By Amnon Ron|2022-03-27T20:51:22+00:00March 27th, 2022|All|Comments Off on Dr. Eolia Brissot – Approval of maribvir for post-transplant cytomegalovirus infection
By Amnon Ron|2021-09-09T15:44:58+00:00September 9th, 2021|All|Comments Off on Annalisa Ruggeri – Haplo versus matched unrelated transplant at the era of post-cyclophosphamide
